Our History

Safapac (Cambridge) Ltd was founded in 1996, following the management buy-out of Syngenta’s (the Ciba-Geigy) UK agrochemical and veterinary factory. The privately owned chemical contract manufacturing and packing business relocated to its current premises in Peterborough in 2006, and subsequently changed name to Safapac Ltd. The business has since continued to grow and flourish, adapting to new markets and meeting evolving customer requirements.

Although a clear front runner in the manufacture and packing of agricultural products (largely pesticides – insecticides, fungicides, herbicides etc.), the adaptability of the Safapac facility and expertise of staff has allowed it to expand into other market sectors over the years – notably the veterinary medicines, medical disinfectants and hard surface cleaner industries.

In 2014, a new Enterprise Resource Planning (ERP) system was installed, allowing accurate and real-time batch control information to be generated; individual works orders to be made and all analytical results to be stored.

In 2015, a larger suspension concentrate plant was installed, increasing herbicide manufacturing capacity by 300% . This segregated state-of-the-art chemical blending plant has not only allowed a new product base, but an increased production flexibility and turnaround time.

From 2016 a dedicated pilot plant has enabled us to successfully establish a number of new products for customers, working through scaling issues and taking their product from lab to full scale production.

In 2018, we purchased three additional building units ( 3 x 10,000 sqft.) in Peterborough allowing the introduction of storage and logistic services to our portfolio.

The success of the pilot plant has allowed us to progress development into high potency herbicide manufacture. From 2019 our high potency plant has been undertaking pilot trials of new product ranges for our customers.

In early 2020 a new small pack facility was built in unit 40 Stapledon Road, specifically designed to comply with GMP requirements. This new facility has enabled the manufacturing and packing of tablets and liquids into containers as small as 5ml.

The business continues to evolve to meet the changes in market needs.